Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

M. Diamant, M.A. Nauck, R. Shaginian, J.K. Malone, S. Cleall, M. Reaney, D. de Vries, B.J. Hoogwerf, L. MacConell, B.H.R. Wolffenbuttel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2763-2773
JournalDiabetes Care
Issue number10
Publication statusPublished - 2014

Cite this